ReviewCancers2025

Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments.

Denise Drittone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.